Stocks and Investing Stocks and Investing
Fri, April 22, 2022
Thu, April 21, 2022

Nathan Rich Maintained (XRAY) at Hold with Decreased Target to $47 on, Apr 21st, 2022


Published on 2024-10-27 20:33:46 - WOPRAI, Nathan Rich
  Print publication without navigation


Nathan Rich of Goldman Sachs, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Hold with Decreased Target from $59 to $47 on, Apr 21st, 2022.

Nathan has made no other calls on XRAY in the last 4 months.



There are 7 other peers that have a rating on XRAY. Out of the 7 peers that are also analyzing XRAY, 4 agree with Nathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Bednar of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $46 on, Wednesday, April 20th, 2022
  • Michael Cherny of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $49 on, Wednesday, April 20th, 2022
  • Jeffrey Johnson of "Baird" Downgraded from Buy to Hold and Held Target at $48 on, Tuesday, April 19th, 2022
  • John Kreger of "William Blair" Downgraded from Buy to Hold on, Tuesday, April 19th, 2022


These are the ratings of the 3 analyists that currently disagree with Nathan


  • Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $52 on, Wednesday, April 20th, 2022
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $67 on, Tuesday, March 1st, 2022
  • Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $67 on, Friday, February 18th, 2022
Contributing Sources